Comparison of Fine Needle Aspiration Cytology (FNAC) and Tru-cut Biopsy for the Diagnosis of Palpable Breast Lumps at a Tertiary Care Centre in Rural Area of Faridabad, Haryana

Read full text Summarise with VIRAT
Authors: Malika Mehta Aggarwal, Shafaque Zabin, Shweta Chaturvedi, Samreen Naqash, Sanyam Seth
Cited by: 0
References: 12

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Breast cancer is the most common malignancy among Indian women. Timely and accurate diagnosis of palpable breast lumps is critical for appropriate management. Fine Needle Aspiration Cytology (FNAC) and Tru-cut biopsy are commonly used diagnostic modalities. While FNAC is minimally invasive and cost-effective, Tru-cut biopsy provides core tissue for histopathological and immunohistochemical evaluation, potentially improving diagnostic accuracy. Objectives: To compare the diagnostic accuracy of FNAC and Tru-cut biopsy in distinguishing benign from malignant breast lesions. To evaluate sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall diagnostic efficacy of both techniques. Methods: A retrospective comparative study was conducted over 24 months at a tertiary care center in rural Faridabad, Haryana. A total of 106 patients presenting with palpable breast lumps were included, excluding those with infective or traumatic etiologies. All patients underwent both FNAC and Tru-cut biopsy, followed by histopathological correlation post-surgery. Results: Tru-cut biopsy demonstrated superior diagnostic performance with a sensitivity of 97.37%, specificity of 96.67%, PPV of 98.67%, NPV of 93.55%, and overall accuracy of 97.16%. FNAC yielded a sensitivity of 85.53%, specificity of 86.67%, PPV of 94.20%, NPV of 70.27%, and accuracy of 85.84%. FNAC correctly identified 85.8% of cases, whereas Tru-cut biopsy showed stronger concordance with final histopathology results. Conclusion: FNAC remains a valuable initial diagnostic tool due to its simplicity, affordability, and rapid results. However, Tru-cut biopsy offers significantly higher diagnostic accuracy and is especially beneficial in cases where FNAC results are inconclusive. Given its superior performance metrics, Tru-cut biopsy should be incorporated into routine diagnostic protocols alongside FNAC, as part of the WHO-recommended triple assessment for breast lesions.

Fields of Study & Subjects

Breast Lesions and Carcinomas Breast Cancer Treatment Studies AI in cancer detection

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
03
Publication date
15 March 2026
Language
EN